Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2025-12-26 @ 2:11 AM
NCT ID: NCT03912805
Description: None
Frequency Threshold: 0
Time Frame: 26 Weeks
Study: NCT03912805
Study Brief: ET-01 in Subjects With Lateral Canthal Lines, LCL-209
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ET-01 1610U botulinum toxin, Type A, topical liniment, administered once at baseline botulinum toxin, Type A: topical liniment 0 None 0 19 2 19 View
Vehicle Vehicle, topical liniment, administered once at baseline Vehicle: Vehicle Formulation 0 None 0 19 6 19 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Upper Respiratory Tract Infection SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (21.0) View
Thermal Burn SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (21.0) View
Folliculitis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (21.0) View
Endodontic Procedure SYSTEMATIC_ASSESSMENT Surgical and medical procedures MedDRA (21.0) View
Oral Herpes SYSTEMATIC_ASSESSMENT General disorders MedDRA (21.0) View
Nephrolithiasis SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (21.0) View
Urinary Tract Infection SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (21.0) View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (21.0) View
Hordeolum SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (21.0) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (21.0) View